Patent & IP news for June 18, 2015
Patent Litigations
- Meda Pharmaceuticals Inc. v. Roxane Laboratories, Inc. et. al. filed 2 days ago in Delaware
- Matter et. al. filed yesterday in California Central
- Gene Reader LLC v. Tecan U.S., Inc. filed yesterday in Texas Eastern
- Gene Reader LLC v. Agilent Technologies, Inc. filed yesterday in Texas Eastern
- v. Hess Print Solutions filed yesterday in Ohio Northern
- Tridia Corporation v. Parallels. Inc. filed 2 days ago in Georgia Northern
- Hetero Labs Ltd, Unit V et. al. v. Pharmacia & Upjohn Company LLC filed yesterday in Illinois Northern
- I. Spiewak & Sons, Inc. filed yesterday in New York Southern
- Mass Engineered Design, Inc. v. Milestone AV Technologies, LLC d/b/a Chief Manufacturing et. al. filed yesterday in Texas Eastern
- CTP Innovations, LLC filed yesterday in Oregon
- Global Allies, LLC v. JL Furnishings LLC et. al. filed yesterday in California Northern
- Merz North America, Inc. v. Cytophil, Inc. filed yesterday in North Carolina Eastern
- Hawk Technology Systems, LLC v. Nexstar Broadcasting, Inc. filed yesterday in California Eastern
- Cascade Designs, Inc v. Thunder Box, Inc filed yesterday in Washington Western
- Cascade Designs, Inc v. Thunder Box, Inc filed yesterday in Washington Western
- Microstrategy Incorporated v. Apttus Corporation filed yesterday in Texas Eastern
USPTO Weekly Stats
9,302
published
appl'ns
appl'ns
5,268
granted
patents
patents
64
ptab
decisions
decisions
Patent & IP Blogs
French toast leaves a sour taste for Battistelli on EPO's big day from ipkitten.blogspot.com The management of the European Patent Office has generally been able to count on public expressions of support and smiling photo opportunities with national politicians when EPO President Benoît Battistelli goes offsite on his travels ...
When the business is over: an IP enthusiast's thoughts from San Francisco from ipkitten.blogspot.com This Kat at the Gala DinnerAfter two very intensive 20-hour days of IP conferencing at IPBCGlobal 2015 [reported in nine blogposts on IP Finance and one on this weblog too], in which this Kat ...
Meet the Biotechnology Innovation Organization from www.patentdocs.org
From the 2015 BIO International Convention in Philadelphia, PA Will a rose by any other name . . .? As part of his remarks during the Keynote Luncheon earlier today at the Biotechnology Industry Organization (BIO) International Meeting ...
From the 2015 BIO International Convention in Philadelphia, PA Will a rose by any other name . . .? As part of his remarks during the Keynote Luncheon earlier today at the Biotechnology Industry Organization (BIO) International Meeting ...
Institution of IPR For One of Two Asserted Patents No Basis for Stay from docketreport.blogspot.com
The court denied defendants' motion for a continued stay pending inter partes review after the PTAB instituted review of only one patent-in-suit. "The [granted] petition only addresses three out of the eleven asserted claims in ...
The court denied defendants' motion for a continued stay pending inter partes review after the PTAB instituted review of only one patent-in-suit. "The [granted] petition only addresses three out of the eleven asserted claims in ...
Has the Copyright Board Taken a Substantial Position on Substantial Parts? from www.iposgoode.ca
What does it mean to be “substantial”? No, this is not the kind of question that requires a long reflective look in the mirror (unless that’s your thing…I’m more of the “stare ...
What does it mean to be “substantial”? No, this is not the kind of question that requires a long reflective look in the mirror (unless that’s your thing…I’m more of the “stare ...
Announcing the Winners of the Gowlings Best Blog in IP Law and Technology Prize from www.iposgoode.ca
IP Osgoode would like to congratulate the winners of the Gowlings Best Blog in IP Law and Technology Prize for 2014-2015. Four prizes in total are awarded each year to Osgoode students and the winning ...
IP Osgoode would like to congratulate the winners of the Gowlings Best Blog in IP Law and Technology Prize for 2014-2015. Four prizes in total are awarded each year to Osgoode students and the winning ...
WIPO: Roving Seminars Reach Out To Stakeholders In Developed Countries from www.ip-watch.org
The World Intellectual Property Organization has initiated a programme of reaching out to stakeholders in developed countries with “roving seminars” on WIPO services and initiatives. The programme targets potential WIPO customers, promotes local IP services ...
The World Intellectual Property Organization has initiated a programme of reaching out to stakeholders in developed countries with “roving seminars” on WIPO services and initiatives. The programme targets potential WIPO customers, promotes local IP services ...
As to "promote the progress," note issues in scientific journals--Misconduct and poor laboratory practice in science threatens the scientific progress from ipbiz.blogspot.com
In a post in The Scientist titled Widespread Data Duplication, Kerry Grens discusses work by
Morten P. Oksvold in the June 2015 issue of Science and Engineering Ethics :
Oksvold had collected 40 papers continuously as ...
In a post in The Scientist titled Widespread Data Duplication, Kerry Grens discusses work by
Morten P. Oksvold in the June 2015 issue of Science and Engineering Ethics :
Oksvold had collected 40 papers continuously as ...
Tips for arguing Unexpected Results Arguments to overcome obviousness from allthingspros.blogspot.com
MPEP Sections 716 and 2145 provide a good primer on arguing unexpected results in order to overcome obviousness. To dig into the topic in a little more detail, this post will discuss a number of ...
MPEP Sections 716 and 2145 provide a good primer on arguing unexpected results in order to overcome obviousness. To dig into the topic in a little more detail, this post will discuss a number of ...
Tech policy primer for Presidential candidates (1) from www.athenaalliance.org
Yesterday, my friends over at the Information Technology and Innovation Foundation (ITIF) released a new report on Tech Policy 2016: What Presidential Candidates Should Be Talking About. The report is written as a memo for ...
Yesterday, my friends over at the Information Technology and Innovation Foundation (ITIF) released a new report on Tech Policy 2016: What Presidential Candidates Should Be Talking About. The report is written as a memo for ...
Tech policy primer for Presidential candidates (2) from www.athenaalliance.org
As I noted in my earlier posting, ITIF has published a version of what it would like to hear from the Presidential candidates. Here is the campaign speech I would like to hear: America has ...
As I noted in my earlier posting, ITIF has published a version of what it would like to hear from the Presidential candidates. Here is the campaign speech I would like to hear: America has ...
Is Derek Khanna wrong on patent reform? from ipbiz.blogspot.com
Within Derek Khanna's The U.S. Patent System is Broken: Derek Khanna on Trolling and Low-Quality Patents, one finds a number of mistakes:
"A patent is a government-granted monopoly" that gives the owner sole ...
Within Derek Khanna's The U.S. Patent System is Broken: Derek Khanna on Trolling and Low-Quality Patents, one finds a number of mistakes:
"A patent is a government-granted monopoly" that gives the owner sole ...
Samsung requests full-court review of appellate decision on Apple's design patents: claim construction, damages from www.fosspatents.com
Samsung filed a petition yesterday for an en banc (full-court) rehearing concerning the design patents-related issues relating to the Federal Circuit's mid-May appellate opinion in the first Apple v. Samsung case. Apple did not ...
On remand, CAFC holds that Teva's Group I claims are invalid for indefiniteness; Teva loses. from ipbiz.blogspot.com
The CAFC noted:
On remand, the parties submitted supplemental briefing
explaining how the appeal should be resolved in light of
the Supreme Court’s Teva decision.
See Teva Pharm. USA, Inc. v. Sandoz, Inc., No ...
The CAFC noted:
On remand, the parties submitted supplemental briefing
explaining how the appeal should be resolved in light of
the Supreme Court’s Teva decision.
See Teva Pharm. USA, Inc. v. Sandoz, Inc., No ...
CAFC vacates injunction and contempt order in ePlus v. Lawson from ipbiz.blogspot.com
Because the USPTO had cancelled claim 26 in a re-exam, the CAFC vacated an injunction and contempt order.
link: http://www.cafc.uscourts.gov/images/stories/opinions-orders/13-1506.Opinion.6-16-2015.1.PDF
Because the USPTO had cancelled claim 26 in a re-exam, the CAFC vacated an injunction and contempt order.
link: http://www.cafc.uscourts.gov/images/stories/opinions-orders/13-1506.Opinion.6-16-2015.1.PDF
UN Expert Urges Encryption, Anonymity Online To Preserve Freedom Of Expression from www.ip-watch.org
A United Nations expert on freedom of expression this week has brought international attention to the need for individuals to be able to share completely encrypted, anonymous communications on the internet in order to preserve ...
A United Nations expert on freedom of expression this week has brought international attention to the need for individuals to be able to share completely encrypted, anonymous communications on the internet in order to preserve ...
Teva v. Sandoz: On remand, Still No Deference and Claim is Indefinite from patentlyo.com
Taking up the remand from the Supreme Court, a divided Federal Circuit panel has held true to its prior decision in Teva v. Sandoz – holding once again that the lower court’s claim construction was ...
Taking up the remand from the Supreme Court, a divided Federal Circuit panel has held true to its prior decision in Teva v. Sandoz – holding once again that the lower court’s claim construction was ...
Surfs up for Glatopa ( glatiramer acetate injection for relapsing MS )? from ipbiz.blogspot.com
Of the decision in Teva v. Sandoz related to Copaxone,
as to legal matters:
To the extent that Teva argues that the meaning of
“molecular weight” in the context of patents-in-suit is
itself a question ...
Of the decision in Teva v. Sandoz related to Copaxone,
as to legal matters:
To the extent that Teva argues that the meaning of
“molecular weight” in the context of patents-in-suit is
itself a question ...
Cephalon v. Abraxis: Abraxane Does Not Infringe Cephalon's Patent Claiming Porous Paclitaxel Matrices from holmansbiotechipblog.blogspot.com
On June 17, 2015, the Federal Circuit affirmed a district court’s determination in Cephalon v. Abraxis that Celgene’s Abraxane drug product, which contains a fast-dissolving form of paclitaxel, did not infringe Cephalon’s ...
On June 17, 2015, the Federal Circuit affirmed a district court’s determination in Cephalon v. Abraxis that Celgene’s Abraxane drug product, which contains a fast-dissolving form of paclitaxel, did not infringe Cephalon’s ...
Some content © 2007–2015 RPX Corporation.
Terms of Service & Privacy Policy
For DMCA requests contact help@priorsmart.com.
Terms of Service & Privacy Policy
For DMCA requests contact help@priorsmart.com.